|Bid||0.00 x 800|
|Ask||0.00 x 800|
|Day's Range||481.38 - 488.27|
|52 Week Range||317.06 - 574.33|
|Beta (5Y Monthly)||1.14|
|PE Ratio (TTM)||72.58|
|Earnings Date||Jan 31, 2023 - Feb 06, 2023|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||479.63|
IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in pet healthcare innovation, has scheduled the release of its 2022 fourth quarter and full year financial results for Monday, February 6, 2023 before the market opens. The Company will conduct an analyst conference call beginning at 8:30 a.m. ET on that day.
In the daily bar chart of IDXX, below, I see a base pattern and an upside breakout and rally. The On-Balance-Volume (OBV) line is showing strength in January after a long sideways move from May. The Moving Average Convergence Divergence (MACD) oscillator is above the zero line but shows some narrowing that needs to be monitored. The weekly OBV line has been improving since October.
Idexx (IDXX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.